Praxis Precision Medicines (PRAX) said late Tuesday it plans a public offering of common shares and pre-funded warrants.
The company will grant underwriters a 30-day overallotment option to buy up to an additional 15% of the common shares offered, according to a statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.